Design and Process Development for Smart Phone Medication Dosing Support System and Educational Platform in HIV/Aids-TB Programs in Zambia by Willig, M. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Population and Quantitative Health Sciences 
Publications Population and Quantitative Health Sciences 
August 2010 
Design and Process Development for Smart Phone Medication 
Dosing Support System and Educational Platform in HIV/Aids-TB 
Programs in Zambia 
M. Willig 
University of Alabama 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/qhs_pp 
 Part of the Biostatistics Commons, Biotechnology Commons, Computer Engineering Commons, 
Electrical and Computer Engineering Commons, Epidemiology Commons, and the Health Services 
Research Commons 
Repository Citation 
Willig M, Sinkala M, Sadasivam RS, Albert M, Wilson L, Mugavero M, Msidi E, Brande S, Nikisi J, Stringer J, 
Tami I, Henostroza G, Gathibhande V, Menke J, Tanik MM, Reid S. (2010). Design and Process 
Development for Smart Phone Medication Dosing Support System and Educational Platform in HIV/Aids-
TB Programs in Zambia. Population and Quantitative Health Sciences Publications. Retrieved from 
https://escholarship.umassmed.edu/qhs_pp/853 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Population and 
Quantitative Health Sciences Publications by an authorized administrator of eScholarship@UMMS. For more 
information, please contact Lisa.Palmer@umassmed.edu. 
Integrated Design and Process Technology, IDPT 2009 
Printed in the United States of America, November, 2009 
© 2009 Society for Design and Process Science 
 
 1
 
DESIGN AND PROCESS DEVELOPMENT FOR SMART PHONE 
MEDICATION DOSING SUPPORT SYSTEM AND EDUCATIONAL 
PLATFORM IN HIV/AIDS-TB PROGRAMS IN ZAMBIA 
M. Willig1, M. Sinkala, R. S. Sadasivam3, M. Albert, L. Wilson4, M. Mugavero1,  
E. Msidi, S. Brande5, J. Nikisi6, J. Stringer9, I. Tami7, G. Henostroza1,9,  
V. Gathibhande8, J. Menke9, M. Tanik8, S. Reid1,9 
 
1Department of Medicine, Division of Infectious Diseases, UAB 
3Division of Health Informatics and Implementation Science, University of 
Massachusetts Medical School 
4Department of Family/Child health and Caregiving, School of Nursing, UAB 
5Department of Chemistry, UAB 
6Jhpiego – Johns Hopkins University affiliate, Lusaka, Zambia 
7Department of Epidemiology, School of Public Health, UAB 
8Department of Electrical and Computer Engineering, UAB 
9Centre for Infectious Disease Research in Zambia (CIDRZ) 
 
UAB – University of Alabama at Birmingham 
Birmingham, Alabama 35294 
 
ABSTRACT 
The widespread adoption of cell phones and other 
mobile platforms represents an opportunity to extend the 
benefits of personalized, point-of-care, healthcare 
applications to providers and patients in the developing 
world. However, the challenges facing the effective 
deployment of mobile health care applications are 
complex, and thus require a scalable, flexible, and 
configurable approach. A service-oriented-architecture-
based conceptual framework is proposed to address the 
challenges of developing and deploying mobile health 
care applications. A particular emphasis of the 
framework is a service-agent-modeling-based composite 
process-personalization support that is needed to support 
the diverse and adaptable needs of the users.  
INTRODUCTION 
Once thought impossible, the dedication and efforts 
of countless international organizations and individuals 
have made HIV/AIDS therapy available in developing 
nations where it is estimated 90% of global cases are 
present. Despite the vastly improved access to 
antiretroviral therapy (ART), in 2007 World Health 
Organization (WHO) estimates indicated only 31% of 
those infected in low- and middle income countries had 
accessed HIV/AIDS therapy (Munjanja et al, 2005; 
PEPFAR, 2009; WHO, 2006). Reduced human resources 
are a key barrier to the provision of HIV care in resource 
limited settings. Contributing factors include a limited 
supply of new healthcare workers coming into the 
workforce, inadequate human resource management 
systems for recruitment, deployment and retention, 
attrition due to HIV/AIDS, limited career and 
professional opportunities, and increasing rates of 
international migration (Munjanja et al, 2005; WHO 
2008a; WHO 2008b).  In response to these shortages, and 
to maximize available human resources, the World 
Health Organization (WHO) published guidelines related 
to task-shifting, the strategy of moving tasks from highly 
qualified health workers to workers with shorter duration 
training needs.  Alongside task-shifting, the WHO 
stresses the need for efforts to increase the overall 
number of trained healthcare workers and to establish 
appropriate quality assurance mechanisms to evaluate 
and monitor clinical outcomes.  
HIV care has become increasingly complicated due 
to a number of factors.  The complexity of dosing 
antiretroviral therapy continues to expand as more agents 
are added to the treatment arsenal and older drugs are co-
formulated into new combinations.  Providers are prone 
to various dosing errors if they fail to account for 
multiple patient characteristics at the time of prescription 
(Purdy et al., 2000; Rastegar et al., 2006). At the 
University of Alabama at Birmingham HIV care clinic, 
we found dosing errors occurred in 6% of all 
prescriptions and in 31% of those in patients with renal 
dysfunction (Willig et al., 2007).  Dosing errors may lead 
to increased drug toxicity, which in turn may adversely 
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affect adherence to therapy and hasten the development 
of drug resistant virus and regimen failure, which 
impacts HIV/AIDS morbidity and mortality. In the 
developing world, having to move from a first line 
regimen to a second line regimen increases the cost of 
ART tenfold (Sukasem et al., 2007; Sungkanuparph et 
al., 2007; Marconi et al., 2008). At present, third line 
regimens do not exist, meaning the development of 
resistance to second line regimens leaves patients without 
therapeutic options.    
An additional challenge is that patients with 
advanced HIV/AIDS often need concomitant treatment 
for co-existing opportunistic infections such as 
tuberculosis (TB).  Agents used to treat TB often interact 
with drugs used to treat HIV, resulting in changes in 
serum levels that may contribute to toxicity (elevated 
drug levels) or treatment failure (lowered drug levels) 
(Onyebujoh et al., 2007; Lalloo and Pillay, 2008; Scano 
et al., 2008; Manosuthi et al., 2009). Faced with the 
challenge of appropriately dosing complex ART and TB 
regimens, providers would benefit from targeted 
informatics tools that would assist the prescription of 
appropriately dosed therapy. We are proposing to 
develop such a tool in collaboration with front line care 
providers in Zambia. We propose the utilization of 
mobile phone technology due to its penetration, ease of 
use and familiarity to users, and its potential to harbor 
software. Such a mobile phone system will not only 
allow for dosing decision support at the point of care, but 
it will also serve as a platform for the dissemination of 
continuing medical education, and enhance the skills of 
care providers longitudinally.  Such a strategy holds the 
promise of helping patients by decreasing toxicity and 
maximizing effectiveness, as well as providing a 
practical tool that can monitor quality assurance.  
Monitoring patterns of prescription error can provide 
insight into areas where educational intervention is 
needed.  What follows is a summary of a staged approach 
for the development of such software.  We anticipate that 
such expert dosing software could play an important role 
in minimizing dosing errors, monitoring quality of care, 
and targeting educational interventions as task-shifting 
initiatives are increasingly implemented throughout the 
world.   
REQUIREMENTS  
The goal is to create a flexible software tool that 
could be utilized at the front lines of HIV and TB care in 
resource limited settings.  The tool must be:  
 
User friendly:  The tool should provide clear value to 
providers.  The input of patient and planned treatment 
information should be simple, and result in readily 
interpretable and patient specific dosing 
recommendations.  To accomplish this goal, patient 
specific characteristics (i.e. height, weight, pertinent 
laboratory values, etc.) will need to be entered before a 
planned treatment is formulated.  The application will 
then calculate and present individualized treatment and 
dosing recommendations based on patient characteristics.   
 
Flexible:  It must allow for easy and accurate capture and 
storing of this information in a central database for later 
access.  Though much data (i.e. drug dosing 
recommendations) will be portable across settings, the 
application must be flexible enough to allow for some 
individualization of treatment recommendations based on 
the needs and available drugs in specific settings.   
 
Accessible:  The application needs to be readily 
deployable in resource rich and resource limited settings.  
Due to their penetration and rapidly increasing 
computing power, we feel mobile phones provide an 
optimal platform for dissemination of this application.  
The application could be installed on mobile phones and 
provide recommendations even at times without ready 
access to phone networks.  Educational modules could be 
automatically downloaded to provider phones when in a 
service area, to be accessed and completed later.  
Evaluations of these modules would be uploaded 
automatically, and scores sent back to providers once 
they return to service areas.  In this fashion, one can 
envision each HIV treatment program establishing 
continuing education requirements and have a platform 
in place to readily disseminate such interventions.  
Likewise, in case it becomes necessary to communicate 
to providers new scientific findings that would have an 
impact on current practice, a network to send and track 
review of these data would be in place.  This new 
network might also be used to disseminate information 
on new epidemics or other public health emergencies.   
 
Prepared for additional linkage:  At the central 
repository for information, individual patients will have a 
system wide identifier (primary key), around which the 
data structures will be organized.  By structuring the data 
this way, the toolset may later be able to link to and 
display information captured throughout the healthcare 
system (laboratory, medication history/changes at other 
sites, dates/times/locations of previous visits, etc).  
Laying the foundation to be able to potentially organize 
and later share information from a central site will allow 
future healthcare providers to have reliable information 
on past care that patients have received.  For example, 
such thorough capture of historical information will 
enable providers to make optimal treatment decisions 
based on comprehensive knowledge of past medication 
exposure.  It has been reported that as many as 40-50% 
of patients are lost to follow up from where they began to 
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receive HIV care in developing nations.  Loss to follow 
up is associated with poor treatment outcomes and 
increased mortality.  The capture of the proposed data 
through a national network of mobile phones could 
provide insight into patient histories across multiple sites 
of care. These data in turn could help guide the 
development of interventions to mitigate the risks of 
“losing” patients and ultimately improve HIV care 
outcomes.  Laying the foundation to cross link to other 
databases from the very beginning will lay the 
groundwork for potentially expanding the functionality 
of this application in the future.   
FUNCTIONAL REQUIREMENTS  
Initially, this application will provide point of care 
assistance in the dosing of antiretroviral and tuberculosis 
therapy.  This will only represent the first stage of 
application development, with further phases and 
correspondingly expanded functionality to follow.  
Below we propose a “growth plan” for the application, 
the development of additional functionality seeking to 
respond to the most pressing needs of our partners.   
 
Stage 1:  Provision of educational materials. The 
mobile application will allow the display of documents 
such as national guidelines for the treatment of HIV 
and/or TB therapy.  These will be updated and sent to 
providers periodically as soon as new iterations become 
available.  Continuing medical education modules which 
test providers on their knowledge of important changes to 
treatment recommendations could be delivered as well.  
This will allow national programs ready access to a 
distance education network that will potentiate their 
ability to disseminate needed guidelines in a timely 
fashion to the field.   
 
Stage 2:  Decision support for adult dosing 
recommendations for HIV and/or TB therapy. Guided 
by comprehensive review of drug prescribing 
information, a set of rules governing the appropriate 
dosing of adult HIV and TB therapy will be completed.  
These rules will include the detection of interactions 
between therapies for illnesses that could compromise 
drug levels to the detriment of those under care (high 
drug levels leading to toxicity, or low drug levels leading 
to loss of effectiveness).  The clinical parameters that 
need to be taken into account in the dosing of each drug 
will be entered into a streamlined form. After entry, 
providers will be asked to select the planned therapeutic 
regimen.  Upon completion, the application will generate 
dosing recommendations for the relevant drugs for the 
specific patient.  In this manner, patient specific dosing 
will be calculated taking into account such factors as 
weight, CD4 value, creatinine clearance, co-
administration of HIV and TB therapy.   
 
Stage 3:  Decision support for pediatric dosing 
recommendations for HIV and/or TB therapy. Dosing 
TB and HIV therapy in children represents additional 
challenges.  The addition of the patient characteristics 
needed to generate appropriate dosing recommendations 
for HIV and TB infected children will be included.  
Decision support taking into account the relevant clinical 
characteristics will be generated at the point of care. 
 
Stage 4:  Addition of drug interactions.  We will 
extend the capabilities of the application to provide 
guidance on drug interactions covering all potential 
medications the patient could be using.  The average life 
expectancy of HIV positive individuals is calculated to 
be approximately 70 years of age.  As our HIV infected 
population ages and requires additional medication for 
other concomitant medical conditions (e.g., cardiac 
disease or diabetes), the ability to easily and reliably 
check for drug interactions with the existing HIV 
treatment regimen will increase in importance.  We will 
explore standalone applications to add such functionality, 
and work with strategic partners or knowledge vendors to 
acquire databases that can be used for this purpose.  
 
Stage 5:  Linkage to existing databases and central 
information repository. Herein lies the potential to 
expand the utility of this application in the future.  An 
example would be linkage to existing national laboratory 
databases that would allow access to laboratory data on 
all patients wherever providers have access to a mobile 
phone network.  If one were to add linkage to patient 
HIV drug resistance reports, it will greatly aid in the 
selection of optimal new regimens.  A consequence of 
the expansion of the use of mobile applications to receive 
feedback on appropriate dosing is that the recommended 
regimens could be stored in the central database along 
with stop dates.  When another provider in a different 
geographic setting is starting subsequent therapy, a 
record of the initiation dates and agents utilized in the 
past would be available.  Currently, a “history of prior 
agents” often depends exclusively on patient recollection.  
The ability to have access to well characterized past 
regimen data will present health care providers with 
comprehensive drug histories that will allow for the 
initiation of optimal subsequent therapy.   
LOOKING AHEAD 
A mobile phone application, well adapted and 
appropriately implemented in daily clinical practice in 
the targeted settings, will enable providers to potentially 
avoid erroneous prescription of HIV and TB therapy.  
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The establishment of a national network of providers 
using such an application will allow health ministries to 
disseminate guidelines and complete continuing medical 
education initiatives in rapid fashion.  Use of tools, such 
as the application described, have the potential to allow 
for monitoring of HIV and TB outcomes for healthcare 
providers serving patients as part of task-shifting 
initiatives.  These data will be necessary to evaluate the 
effectiveness of task-shifting initiatives, as well as 
allowing the detection of issues that will help to target 
continuing medical education for such providers.  
Building a system with the foundation in place to capture 
the data that will allow for the optimal selection of future 
therapy in resource limited settings will serve to provide 
reliable databases that will improve longitudinal patient 
care.  This will be critical in HIV therapy where the 
current paradigm calls for lifelong ART, and subsequent 
treatment decisions are influenced by prior treatment and 
resistance history.  Due to the expanding computing 
capacity, increased penetration of mobile phone networks 
and newer alternatives such as solar-powered cell 
phones, this technology allows for the deployment of 
software tools in remote settings where comprehensive 
informatics resources are lacking.  Through carefully 
crafted software applications, we can bring many of the 
benefits of medical informatics to resource limited 
settings.   
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